Sorafenib is a multikinase inhibitor studied for its role in cancer treatment. It is characterized as an aromatic, heterocyclic compound containing amide, ether, and halogen functional groups.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 284461-73-0
Sorafenib tosylate
pharmaceutical raw material
Regorafenib
pharmaceutical raw material
Regorafenib monohydrate
pharmaceutical raw material
4-[4-[[[[2-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide
pharmaceutical intermediate
3-Chloroanisole
Research intermediate
Methyl 3,5-dichloro-4-hydroxybenzoate--water (1/1)
Laboratory reagent
Heptylboronic acid
Laboratory reagent for research
1-(2-(Ethylthio)ethyl)-2-methyl-5-nitro-1H-imidazole
Pharmaceutical intermediate or research compound
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide
MLDQJTXFUGDVEO-UHFFFAOYSA-N
CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F